Mark Bertolini Sells 614,752 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CEO Mark Bertolini sold 614,752 shares of the company’s stock in a transaction on Monday, June 29th. The shares were sold at an average price of $29.26, for a total value of $17,987,643.52. Following the completion of the sale, the chief executive officer owned 8,375,814 shares in the company, valued at $245,076,317.64. This represents a 6.84% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Trading Up 0.6%

Shares of Oscar Health stock opened at $32.09 on Friday. The business’s fifty day moving average is $24.18 and its two-hundred day moving average is $17.77. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a fifty-two week low of $10.69 and a fifty-two week high of $33.10. The firm has a market cap of $9.67 billion, a PE ratio of -54.38, a P/E/G ratio of 2.23 and a beta of 2.34.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The company had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.90 billion. During the same period in the previous year, the company earned $0.92 EPS. The business’s quarterly revenue was up 52.6% compared to the same quarter last year. Analysts anticipate that Oscar Health, Inc. will post 0.47 earnings per share for the current year.

Wall Street Analysts Forecast Growth

OSCR has been the subject of several analyst reports. Wolfe Research began coverage on shares of Oscar Health in a research note on Tuesday, May 5th. They issued a “peer perform” rating for the company. Jefferies Financial Group upgraded Oscar Health from an “underperform” rating to a “hold” rating and boosted their price target for the company from $10.00 to $16.00 in a report on Monday, April 20th. Barclays upgraded shares of Oscar Health from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $30.00 to $35.00 in a research note on Wednesday, June 10th. Zacks Research lowered Oscar Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 5th. Finally, UBS Group raised their price target on shares of Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Three equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $20.78.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in OSCR. Vanguard Group Inc. increased its position in Oscar Health by 2.7% in the 4th quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock worth $297,477,000 after purchasing an additional 540,851 shares during the last quarter. Geode Capital Management LLC boosted its position in Oscar Health by 2.5% during the fourth quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company’s stock worth $68,964,000 after purchasing an additional 116,430 shares during the period. BIT Capital GmbH boosted its holdings in shares of Oscar Health by 545.0% during the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock worth $88,897,000 after buying an additional 5,227,152 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH grew its position in shares of Oscar Health by 1,097.8% in the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 237,882 shares of the company’s stock valued at $3,418,000 after purchasing an additional 218,022 shares during the last quarter. Finally, Farallon Capital Management LLC grew its holdings in Oscar Health by 146.5% in the 3rd quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company’s stock valued at $68,886,000 after buying an additional 2,163,000 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.